Hudson Bay Capital Management
EUCR

Hudson Bay Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Hudson Bay Capital Management’s Portfolio EUCR Stock Details EUCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$6.53M Sell
2022
Q2 		$6.81M Buy
2022
Q1 		$5.05M Buy
2021
Q4 		$4.23M Hold
2021
Q3 		$4.24M Hold
2021
Q2 		$4.27M Buy
2021
Q1 		$3.92M Sell
2020
Q4 		$4.02M Buy